로딩 중…
지수 로딩 중…
JEIL PHARMA HOLDINGS INC.
002620· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩6,610+0.92%
2026-11-02
Financials
Valuation Metrics
JEIL PHARMA HOLDINGS INC.'s Market Cap is ₩1056B. At end of 2025 it was ₩1284B. Ranked #1170 of 2,410 in KR market (top 49%), #553 of 779 on KOSPI (top 71%), #133 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 58%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 105.58B KRW | KR#1,170/2,410 Sec#133/231 |
| Revenue | 630.89B KRW | KR#537/2,410 Sec#22/231 |
| Net Income | 25.42B KRW | KR#617/2,410 Sec#38/231 |
| Total Assets | 891.76B KRW | KR#511/2,410 Sec#27/231 |
| Net Assets | 470.67B KRW | KR#533/2,410 Sec#32/231 |
| Employees | 36 | KR#2,152/2,410 Sec#200/231 |
| Value | ||
| P/E | 4.15x | KR#302/2,410 Sec#10/231 |
| P/B | 0.22x | KR#212/2,410 Sec#8/231 |
| P/S | 0.17x | KR#324/2,410 Sec#3/231 |
| EV/EBITDA | 12.39x | KR#791/2,410 Sec#45/231 |
| FCF Yield | -7.48% | KR—/2,410 Sec—/231 |
| Profitability | ||
| ROE | 5.40% | KR#1,054/2,410 Sec#72/231 |
| ROA | 2.85% | KR#1,062/2,410 Sec#79/231 |
| Op. Margin | 2.89% | KR#1,261/2,410 Sec#92/231 |
| Revenue Growth | -14.26% | KR#2,016/2,410 Sec#184/231 |
| Earnings Growth | -9.32% | KR#875/2,410 Sec#54/231 |
| Financial Health | ||
| Debt Ratio | 89.47% | KR#1,452/2,410 Sec#171/231 |
| Total Debt | 183.31B KRW | KR#537/2,410 Sec#28/231 |
| FCF | -7.89B KRW | KR#1,629/2,410 Sec#136/231 |
| Cash | 62.69B KRW | KR#654/2,410 Sec#36/231 |
| Current Ratio | 1.20x | KR#1,500/2,410 Sec#155/231 |
| Net Debt/EBITDA | 6.61x | KR#1,106/2,410 Sec#83/231 |
| Dividend | ||
| Div. Yield | 1.02% | KR#1,136/2,410 Sec#64/231 |
| Div. Growth | 40.00% | KR#288/2,410 Sec#14/231 |
| Performance | ||
| 1Y Return | -18.80% | KR#1,071/2,410 Sec#75/231 |
| 1M Return | -11.28% | KR#1,399/2,410 Sec#142/231 |
| From 52W High | -32.89% | KR#484/2,410 Sec#33/231 |
| 1Y MDD | -32.22% | KR#302/2,410 Sec#19/231 |
| Trading | ||
| Volume | 7,433 shares | KR#2,167/2,410 Sec#216/231 |
| Trading Value | 48.9M KRW | KR#1,999/2,410 Sec#211/231 |
| Foreign Own. | 9.89% | KR#481/2,410 Sec#41/231 |
| Per Share | ||
| EPS | 1,592 KRW | KR#527/2,410 Sec#38/231 |
| BPS | 29,466 KRW | KR#387/2,410 Sec#29/231 |
Company Info
동사는 1959년 설립되어 1988년 상장된 제약 지주회사로, 2017년 인적분할을 통해 제일파마홀딩스와 제일약품으로 분리되었음. 종속법인으로 제일약품, 제일헬스사이언스, 제일앤파트너스를 보유하며, 투자수익, 브랜드수수료, 경영자문수수료, 임대수익 등 지주회사 사업을 하고 있음. 투명한 기업지배구조를 바탕으로 관리 효율화를 통해 자회사들의 자율 경영과 책임경영을 발전시키고 있음. 제일파마홀딩스는 1959년에 설립되었으며 서울특별시 서초구에 본사를 두고 있습니다.